[HSF] Fwd: STS MEMBER ALERT: FDA Issues Statement on Use ofAprotinin (Trasylol)

[Claudia Teles]

How are the list´s surgeons dealing with that.
Are you still using it in re-do's, or have you proscribed it.
I mean, some people here are stratifying bleeding risk and renal function
before using aprotinin even in re-do's.
That´s bad. Aprotinin is a nice drug, when well indicated.

Claudia Teles




2007/10/27, alsadd <alsadd at ksu.edu.sa>:
>
> Hal:
> No it is not Ben but Ahmed I am dying to see this STS guidelines on
> Aprotinin. You have been trying for some time to send it. I admire your
> determination. Keep trying, this is the spirit
>
> Ahmed
>
> -----Original Message-----
> From: openheart-l-bounces at lists.hsforum.com
> [mailto:openheart-l-bounces at lists.hsforum.com] On Behalf Of Hgrmd at aol.com
> Sent: Saturday, October 27, 2007 3:46 AM
> To: OpenHeart-L at lists.hsforum.com
> Subject: [HSF] Fwd: STS MEMBER ALERT: FDA Issues Statement on Use
> ofAprotinin (Trasylol)
>
> Ben,
> Hopefully, the message from the STS on aprotinin is included this  time.
> I
> think I'm having difficulty getting past the spam fileters at  HSF.  If it
> doesn't come through, the message is just another death knell  to the
> surgical
> use of aprotinin.  Once again, it is associated with higher  mortality.
>
> Hal
>
>
>
> ************************************** See what's new at
> http://www.aol.com
>
> _______________________________________________
> OpenHeart-L mailing list
>
> Send postings to:
> OpenHeart-L at lists.hsforum.com
>
> To UNSUBSCRIBE, to CHANGE email address, or to view archives:
> http://mmp.cjp.com/mailman/listinfo/openheart-l
>
> All messages transmitted by the OpenHeart-L are subject to the policies
> and
> disclaimers posted at:
> http://www.hsforum.com/listdisclaim
> -----------------------------------------
>



-- 
Claudia Teles
Hemostasis Section - INCARDIO